IDEX Biometrics ASA
IDXAF
$0.002
$0.001100.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -373.53% | 120.39% | -23.04% | -10.21% | 30.04% |
| Total Depreciation and Amortization | 217.87% | -134.09% | 187.96% | -24.21% | 29.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 52.15% | -1,111.26% | 226.00% | -162.48% | 65.12% |
| Change in Net Operating Assets | 18.11% | 53,250.00% | 99.72% | -2,807.69% | 105.30% |
| Cash from Operations | -46.82% | 54.78% | 26.63% | -86.40% | 48.91% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,520.00% | -58.33% | -80.33% | 52.50% | -13.04% |
| Cash from Investing | 112.00% | -110.04% | 441.30% | 15.00% | 260.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 82.22% | 44.39% | 30.47% | -307.82% | -240.37% |
| Issuance of Common Stock | 130.65% | -61.04% | 15,648.39% | -98.99% | 4,632.31% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 225.21% | -65.39% | 356.75% | -113.08% | 25,840.91% |
| Foreign Exchange rate Adjustments | -181.82% | 266.67% | 150.00% | -160.00% | 183.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 195.39% | 0.71% | 88.17% | -208.06% | 205.44% |